Dividends & Buybacks ·
Accuray approves 1-for-40 reverse stock split effective Nov. 9 to regain Nasdaq compliance
ARAYAccuray Inc
The Board of Directors approved a 1-for-40 reverse stock split, reducing issued shares from approximately 120.2 million to roughly 3.0 million and authorized common stock from 400 million to 10 million. The transaction becomes effective at 12:02 a.m. ET on November 9, 2026, with split-adjusted trading beginning that day under the existing symbol ARAY. Fractional shares will be cashed out based on the prior closing price. Accuray designs and manufactures radiation therapy systems for oncology treatment.